Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Sonirid Duo effectively treats benign prostatic hyperplasia.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Finasteride can cause skin rash.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.